Mid Atlantic Bio Angels, Author at MABA

THE TIME IS NOW: ANGEL GROUP INVESTING

-By Anthony Gellert

There’s never been a better time to invest in early-staged startups. Full stop.

Yes, there was a banking crisis in Silicon Valley. Yes, we are still brushing off the effects of the pandemic. Yes, these are very risky assets. But most important, all the asset classes that rely on low interest rates and a bull market are in real trouble. Interest rates are now too low to fully guard against inflation. And too high to make equities the obvious first choice. This especially includes later-staged VC, which relies on frothy IPO markets in which to sell their portfolio companies.

Early-staged [ Read more… ]

Mid Atlantic Bio Angels2023-03-30T13:58:53+00:00March 30th, 2023|

Meet the VC: Yaniv Sneor from Mid Atlantic Bio Angels (MABA)

Learn more about MABA with our co-founder, Yaniv Sneor, on February 27th at 11am (EST) where he will discuss MABA”s investment focus, check sizes MABA can offer, the best time to reach out, and much more.

Register for the Zoom meeting at: https://us06web.zoom.us/meeting/register/tZYuceitqDojGtzt5Pkl2AuR6mTS0O0iiyQe

Mid Atlantic Bio Angels2023-04-08T20:09:40+00:00February 21st, 2023|

Restricted

Posted: January 30, 2023

Happy New Year, and welcome aboard, for those investors who recently joined Sidecar Fund II as investors.

Over the last year, MABA has made several new investments as well as several follow-on investments in existing portfolio companies. A few of these qualified for co-investment by the Fund.

Due to the unique structure of Fund II, which is an open-ended Fund, different investors will end up with different baskets of portfolio companies, depending on the time they joined the Fund.

To make sure that you are able to see updates from the companies in your specific portfolio, we’ve designed and [ Read more… ]

Mid Atlantic Bio Angels2023-04-08T20:08:36+00:00January 30th, 2023|

Is Angel Capital or Venture Capital Right for Your Company?

MABA is regularly approached by companies seeking funds for their life sciences startups (therapeutics, devices, diagnostics and digital health). One of the first things we discuss is their total funding needs to reach an exit, and the difference between angel and venture capital (VC). Understanding the difference can help you set the best strategy for your company. Once you have reached the stage where it is time to raise funds, some companies are better suited for, or would prefer angel funding, while others are more appropriate for venture capital.

There are many differences between angel investors and VCs, including the source [ Read more… ]

Mid Atlantic Bio Angels2024-02-13T13:43:46+00:00December 7th, 2022|

MABA Invests in 3D Shape Sensing Technology

NEW YORK CITY, NEW YORK, UNITED STATES, November 10, 2022 /EINPresswire.com/ — Mid Atlantic Bio Angels Group (MABA) is pleased to announce that it has made an investment in The Shape Sensing Company (TSSC).

TSSC joins a prestigious, carefully selected, group of companies and organizations that reflects MABA’s core mission of supporting early-stage health care entrepreneurs and generating favorable financial returns for its members and investors. The MABA investment included individual investors, MABA’s internal investment Pool III, and the MABA Sidecar Fund II, a co-investment fund for non-MABA members.

“Throughout our due diligence process, TSSC’s strong management and transformative technology received notable [ Read more… ]

Mid Atlantic Bio Angels2023-04-08T20:09:41+00:00November 11th, 2022|

Restricted

Summary

TSSC’s 3D technology can significantly improve device navigation and localization, resulting in safer, faster, and more effective surgical procedures, therefore enabling better patient outcomes, the ultimate goal of medicine.

Documents

The Shape Sensing Company – 2024 Q1 Update

The Shape Sensing Company – 2023 Q4 Update

The Shape Sensing Company – Update 2023 Q1

MABA Invests in 3D Shape Sensing Technology

Website https://shapesensing.com/

Mid Atlantic Bio Angels2024-03-07T20:54:24+00:00November 9th, 2022|

MABA Portfolio company, FEMSelect, raises $9M in Series B Financing

FEMSelect, a company developing EnPlace, a minimally invasive and meshless device for women with pelvic floor issues, raises $9M in Series B funding with participation from Mid Atlantic Bio Angels.

Link to article: https://www.prnewswire.com/news-releases/womens-health-leader-femselect-secures-us9m-series-b-financing-301652846.html

Mid Atlantic Bio Angels2023-04-08T20:09:41+00:00October 19th, 2022|

Digital RESI Angel Investor Panel

MABA founder Yaniv Sneor participates on an Angel Investors Panel at Digital RESI 2020 where he discusses several topics including what angels (and MABA) look for in a company, how angels prefer to invest (priced rounds, not SAFEs), and the benefits of syndication.

Link to article: https://blog.lifesciencenation.com/2022/07/14/from-mid-size-pharma-to-angels-what-do-investors-say-about-market-downturn/

Mid Atlantic Bio Angels2023-04-08T20:09:42+00:00July 14th, 2022|